AI’s shadow medical system| STAT
Every few weeks, another headline announces that artificial intelligence has matched a doctor, beaten a doctor, or is finally ready to become one. The latest wave arrived with familiar force:…
-
-
California Supreme Court sides with Gilead in ‘duty’ to innovate case
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon…
-
FDA panel backs compounded BPC-157, KPV peptides in win for RFK Jr.
Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public…
-
Medicare pushes site-neutral payments for hospitals
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He…
-
What’s the point of primary care?
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust,…
-
FTC settles lawsuit with CVS Caremark over insulin prices
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon…
-
AIDS activists slam Biden R&D deal with Gilead over HIV prevention drug patents
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon…
-
UnitedHealth’s home care audit, Medicare Advantage stars suits
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He…
-
AAIC 2026: Researchers focus on tau, target blood-brain barrier
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. This is the web edition of STAT’s AAIC…
-
Kennedy taps vaccine skeptic for public health emergency role
WASHINGTON — The Trump administration’s pick to oversee preparedness and response to public health emergencies and disasters has questioned the use of the hepatitis B vaccine in infants and raised…
